Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6169 | 1519 | 38.1 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
260 | 3 | NUCL MED//RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING//JOURNAL OF NUCLEAR MEDICINE | 44690 |
957 | 2 | PET CT//NUCL MED//PET | 10802 |
6169 | 1 | PSMA//PROSTATE SPECIFIC MEMBRANE ANTIGEN//C 11 CHOLINE | 1519 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PSMA | authKW | 2495133 | 12% | 69% | 180 |
2 | PROSTATE SPECIFIC MEMBRANE ANTIGEN | authKW | 1921816 | 10% | 65% | 147 |
3 | C 11 CHOLINE | authKW | 577560 | 3% | 57% | 50 |
4 | C 11 CHOLINE PET CT | authKW | 502505 | 2% | 83% | 30 |
5 | F 18 CHOLINE | authKW | 405358 | 1% | 92% | 22 |
6 | CHOLINE PET | authKW | 385403 | 1% | 91% | 21 |
7 | F 18 FLUOROCHOLINE | authKW | 358925 | 2% | 71% | 25 |
8 | PROSTATE CANCER | authKW | 294472 | 41% | 2% | 625 |
9 | CAPROMAB PENDETIDE | authKW | 282663 | 1% | 94% | 15 |
10 | CHOLINE PET CT | authKW | 266034 | 1% | 88% | 15 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Radiology, Nuclear Medicine & Medical Imaging | 17100 | 41% | 0% | 625 |
2 | Urology & Nephrology | 7096 | 20% | 0% | 309 |
3 | Oncology | 2264 | 21% | 0% | 325 |
4 | Chemistry, Medicinal | 399 | 6% | 0% | 84 |
5 | Endocrinology & Metabolism | 96 | 4% | 0% | 66 |
6 | Pathology | 47 | 2% | 0% | 35 |
7 | Medicine, Research & Experimental | 46 | 3% | 0% | 50 |
8 | Biochemical Research Methods | 28 | 2% | 0% | 37 |
9 | Nuclear Science & Technology | 10 | 2% | 0% | 24 |
10 | Biochemistry & Molecular Biology | 6 | 7% | 0% | 106 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PET CT LINZ | 179068 | 1% | 64% | 14 |
2 | PHARMACEUT RADIOCHEM | 151150 | 1% | 40% | 19 |
3 | NUCL MED | 96324 | 29% | 1% | 447 |
4 | MOL BIOIMAGING | 93532 | 1% | 42% | 11 |
5 | AZIENDA OSPED UNIV BOLOGNA | 72357 | 0% | 60% | 6 |
6 | OU NUCL MED | 60302 | 0% | 100% | 3 |
7 | PAD 30 | 60302 | 0% | 100% | 3 |
8 | UROL | 42581 | 32% | 0% | 483 |
9 | CLIN COOPERAT UNIT NUCL MED | 42534 | 1% | 12% | 18 |
10 | UNIV MED ROSTOCK | 41870 | 0% | 42% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 70572 | 7% | 3% | 106 |
2 | JOURNAL OF NUCLEAR MEDICINE | 28928 | 8% | 1% | 121 |
3 | EJNMMI RESEARCH | 20198 | 1% | 5% | 21 |
4 | PROSTATE | 18061 | 4% | 1% | 64 |
5 | MOLECULAR IMAGING AND BIOLOGY | 17553 | 2% | 3% | 29 |
6 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 16375 | 1% | 4% | 21 |
7 | MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 6350 | 1% | 2% | 15 |
8 | NUCLEAR MEDICINE AND BIOLOGY | 5902 | 2% | 1% | 33 |
9 | CLINICAL NUCLEAR MEDICINE | 4797 | 3% | 1% | 40 |
10 | SEMINARS IN NUCLEAR MEDICINE | 4632 | 1% | 1% | 17 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PSMA | 2495133 | 12% | 69% | 180 | Search PSMA | Search PSMA |
2 | PROSTATE SPECIFIC MEMBRANE ANTIGEN | 1921816 | 10% | 65% | 147 | Search PROSTATE+SPECIFIC+MEMBRANE+ANTIGEN | Search PROSTATE+SPECIFIC+MEMBRANE+ANTIGEN |
3 | C 11 CHOLINE | 577560 | 3% | 57% | 50 | Search C+11+CHOLINE | Search C+11+CHOLINE |
4 | C 11 CHOLINE PET CT | 502505 | 2% | 83% | 30 | Search C+11+CHOLINE+PET+CT | Search C+11+CHOLINE+PET+CT |
5 | F 18 CHOLINE | 405358 | 1% | 92% | 22 | Search F+18+CHOLINE | Search F+18+CHOLINE |
6 | CHOLINE PET | 385403 | 1% | 91% | 21 | Search CHOLINE+PET | Search CHOLINE+PET |
7 | F 18 FLUOROCHOLINE | 358925 | 2% | 71% | 25 | Search F+18+FLUOROCHOLINE | Search F+18+FLUOROCHOLINE |
8 | PROSTATE CANCER | 294472 | 41% | 2% | 625 | Search PROSTATE+CANCER | Search PROSTATE+CANCER |
9 | CAPROMAB PENDETIDE | 282663 | 1% | 94% | 15 | Search CAPROMAB+PENDETIDE | Search CAPROMAB+PENDETIDE |
10 | CHOLINE PET CT | 266034 | 1% | 88% | 15 | Search CHOLINE+PET+CT | Search CHOLINE+PET+CT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MAURER, T , EIBER, M , SCHWAIGER, M , GSCHWEND, JE , (2016) CURRENT USE OF PSMA - PET IN PROSTATE CANCER MANAGEMENT.NATURE REVIEWS UROLOGY. VOL. 13. ISSUE 4. P. 226 -235 | 78 | 74% | 16 |
2 | EVANGELISTA, L , BRIGANTI, A , FANTI, S , JONIAU, S , RESKE, S , SCHIAVINA, R , STIEF, C , THALMANN, GN , PICCHIO, M , (2016) NEW CLINICAL INDICATIONS FOR F-18/C-11-CHOLINE, NEW TRACERS FOR POSITRON EMISSION TOMOGRAPHY AND A PROMISING HYBRID DEVICE FOR PROSTATE CANCER STAGING: A SYSTEMATIC REVIEW OF THE LITERATURE.EUROPEAN UROLOGY. VOL. 70. ISSUE 1. P. 161 -175 | 72 | 81% | 13 |
3 | KIESS, AP , BANERJEE, SR , MEASE, RC , ROWE, SP , RAO, A , FOSS, CA , CHEN, Y , YANG, X , CHO, SY , NIMMAGADDA, S , ET AL (2015) PROSTATE-SPECIFIC MEMBRANE ANTIGEN AS A TARGET FOR CANCER IMAGING AND THERAPY.QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 59. ISSUE 3. P. 241 -268 | 108 | 79% | 12 |
4 | VON EYBEN, FE , KAIREMO, K , (2014) META-ANALYSIS OF C-11-CHOLINE AND F-18-CHOLINE PET/CT FOR MANAGEMENT OF PATIENTS WITH PROSTATE CANCER.NUCLEAR MEDICINE COMMUNICATIONS. VOL. 35. ISSUE 3. P. 221-230 | 78 | 99% | 27 |
5 | MEASE, RC , FOSS, CA , POMPER, MG , (2013) PET IMAGING IN PROSTATE CANCER: FOCUS ON PROSTATE-SPECIFIC MEMBRANE ANTIGEN.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 13. ISSUE 8. P. 951 -962 | 92 | 75% | 51 |
6 | PILLAI, MRA , NANABALA, R , JOY, A , SASIKUMAR, A , KNAPP, FF , (2016) RADIOLABELED ENZYME INHIBITORS AND BINDING AGENTS TARGETING PSMA: EFFECTIVE THERANOSTIC TOOLS FOR IMAGING AND THERAPY OF PROSTATE CANCER.NUCLEAR MEDICINE AND BIOLOGY. VOL. 43. ISSUE 11. P. 692 -720 | 118 | 70% | 0 |
7 | BROGSITTER, C , ZOPHEL, K , KOTZERKE, J , (2013) F-18-CHOLINE, C-11-CHOLINE AND C-11-ACETATE PET/CT: COMPARATIVE ANALYSIS FOR IMAGING PROSTATE CANCER PATIENTS.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 40. ISSUE . P. S18 -S27 | 80 | 89% | 40 |
8 | LUTJE, S , HESKAMP, S , CORNELISSEN, AS , POEPPEL, TD , VAN DEN BROEK, SAMW , ROSENBAUM-KRUMME, S , BOCKISCH, A , GOTTHARDT, M , RIJPKEMA, M , BOERMAN, OC , (2015) PSMA LIGANDS FOR RADIONUCLIDE IMAGING AND THERAPY OF PROSTATE CANCER: CLINICAL STATUS.THERANOSTICS. VOL. 5. ISSUE 12. P. 1388 -1401 | 67 | 91% | 20 |
9 | UMBEHR, MH , MUNTENER, M , HANY, T , SULSER, T , BACHMANN, LM , (2013) THE ROLE OF 11C-CHOLINE AND 18F-FLUOROCHOLINE POSITRON EMISSION TOMOGRAPHY (PET) AND PET/CT IN PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS.EUROPEAN UROLOGY. VOL. 64. ISSUE 1. P. 106-117 | 63 | 88% | 93 |
10 | FANTI, S , MINOZZI, S , CASTELLUCCI, P , BALDUZZI, S , HERRMANN, K , KRAUSE, BJ , OYEN, W , CHITI, A , (2016) PET/CT WITH C-11-CHOLINE FOR EVALUATION OF PROSTATE CANCER PATIENTS WITH BIOCHEMICAL RECURRENCE: META-ANALYSIS AND CRITICAL REVIEW OF AVAILABLE DATA.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 43. ISSUE 1. P. 55 -69 | 48 | 89% | 10 |
Classes with closest relation at Level 1 |